RxDoctor Payments Data

Shannon Remington, DO

Family Medicine · Knoxville, IANPI 1720202732

Payments from drug & device makers

$653in general payments, 2019–2025

Across 38 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$110
  • Amgen$107
  • Boston Scientific$70
  • Novo Nordisk$65
  • Bayer$63
  • Lilly USA, LLC$61
  • plus $178 from 8 others

What the payments were for

  • Food & beverage$63497%
  • Education$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$653 in reported general payments places this provider in the 75th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$9,137
Medicare patients
18
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$134,290
FarxigaDapagliflozin Propanediol71$72,540
EliquisApixaban74$59,429
JardianceEmpagliflozin34$42,832
MounjaroTirzepatide11$14,724
Cyclosporine18$6,645
SymbicortBudesonide/Formoterol Fumarate24$4,991
Ziprasidone Hcl14$3,229
Ventolin HfaAlbuterol Sulfate49$2,707
Gabapentin130$2,391
Levothyroxine Sodium267$2,198
Potassium Chloride115$2,008
Omeprazole187$1,788
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen72$1,385
Nebivolol Hcl19$1,340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$65$134,290110 claims
AstraZenecaFarxiga, Symbicort$110$77,53195 claims
PfizerEliquis$15$59,42974 claims
Boehringer IngelheimJardiance$56$42,83234 claims
Lilly USA, LLCMounjaro$61$14,72411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Knoxville

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →